Protara Therapeutics (TARA) Competitors

Opthea (NASDAQ:OPT) and Protara Therapeutics (NASDAQ:TARA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, community ranking, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Is OPT or TARA more profitable?

Opthea's return on equity of 0.00% beat Protara Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Opthea	N/A	N/A	N/A
Protara Therapeutics	N/A	-55.96%	-49.06%

Does the MarketBeat Community prefer OPT or TARA?

Protara Therapeutics received 22 more outperform votes than Opthea when rated by MarketBeat users. Likewise, 69.49% of users gave Protara Therapeutics an outperform vote while only 48.72% of users gave Opthea an outperform vote.

Company	Underperform	Outperform
Opthea	Outperform Votes 19 48.72%	Underperform Votes 20 51.28%
Protara Therapeutics	Outperform Votes 41 69.49%	Underperform Votes 18 30.51%

Do analysts prefer OPT or TARA?

Opthea currently has a consensus price target of $1.33, indicating a potential downside of 60.90%. Protara Therapeutics has a consensus price target of $20.40, indicating a potential upside of 527.69%. Given Protara Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Protara Therapeutics is more favorable than Opthea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Opthea	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.17
Protara Therapeutics	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to OPT or TARA?

In the previous week, Protara Therapeutics had 1 more articles in the media than Opthea. MarketBeat recorded 3 mentions for Protara Therapeutics and 2 mentions for Opthea. Protara Therapeutics' average media sentiment score of 1.58 beat Opthea's score of 0.40 indicating that Protara Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Opthea	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Protara Therapeutics	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has higher valuation and earnings, OPT or TARA?

Protara Therapeutics has lower revenue, but higher earnings than Opthea.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Opthea	$87.67K	5,986.77	-$220.24M	N/A	N/A
Protara Therapeutics	N/A	N/A	-$40.42M	-$1.72	-1.89

Do institutionals & insiders have more ownership in OPT or TARA?

56.0% of Opthea shares are held by institutional investors. Comparatively, 38.1% of Protara Therapeutics shares are held by institutional investors. 3.2% of Opthea shares are held by company insiders. Comparatively, 8.4% of Protara Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more volatility and risk, OPT or TARA?

Opthea has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Protara Therapeutics has a beta of 1.73, meaning that its share price is 73% more volatile than the S&P 500.

Summary

Protara Therapeutics beats Opthea on 10 of the 15 factors compared between the two stocks.